Kaletra 200 mg/1
Lopinavir and Ritonavir · TABLET, FILM COATED · AbbVie Inc.
No Recall History
Plain English
Kaletra is a tablet, film coated containing lopinavir and ritonavir at 200 mg/1, taken oral. Manufactured by AbbVie Inc..
Key Facts
- Brand Name
- Kaletra
- Generic Name
- Lopinavir and Ritonavir
- NDC Code (Product)
0074-4014- Manufacturer
- AbbVie Inc.
- Strength
- 200 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA021906
- Drug Class
- Cytochrome P450 3A Inhibitor [EPC]; Protease Inhibitor [EPC]
- Marketing Start
- 04/08/2020
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
drug interaction1,334 reports
depression1,133 reports
nausea781 reports
drug exposure during pregnancy779 reports
diarrhoea775 reports
foetal exposure during pregnancy750 reports
anxiety713 reports
vomiting701 reports
pain694 reports
off label use675 reports
Frequently Asked Questions
What is Kaletra used for?
Kaletra contains Lopinavir and Ritonavir. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is Kaletra a controlled substance?
Kaletra is not classified as a controlled substance by the DEA.
What is the generic name for Kaletra?
The generic name for Kaletra is Lopinavir and Ritonavir. There are 6 other brand versions of Lopinavir and Ritonavir.
What is the NDC code for Kaletra 200 mg/1?
The NDC (National Drug Code) for Kaletra 200 mg/1 is 0074-4014, listed by AbbVie Inc..